Therapeutic effects of the combined androgen blockade therapy versus luteinizing hormone-releasing hormone analog monotherapy in patients with hormone naïve metastatic prostate cancer: a multi-institutional comparative analysis

BACKGROUND: The clinical benefit of the combined androgen blockade (CAB) therapy over luteinizing hormone-releasing hormone analog (LH-RHa) monotherapy for hormone naïve metastatic prostate cancer (mHNPC) is unclear. Therefore, we retrospectively compare the effectiveness of CAB with the LH-RHa mono...

Descripción completa

Detalles Bibliográficos
Autores principales: Narita, Takuma, Hatakeyama, Shingo, Narita, Shintaro, Takahashi, Masahiro, Sakurai, Toshihiko, Kawamura, Sadafumi, Hoshi, Senji, Shimoda, Jiro, Kawaguchi, Toshiaki, Ishidoya, Shigeto, Mitsuzuka, Koji, Arai, Yoichi, Ito, Akihiro, Tsuchiya, Norihiko, Habuchi, Tomonori, Ohyama, Chikara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844496/
https://www.ncbi.nlm.nih.gov/pubmed/33532329
http://dx.doi.org/10.21037/tau-20-966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844496/
https://www.ncbi.nlm.nih.gov/pubmed/33532329
http://dx.doi.org/10.21037/tau-20-966

Ejemplares similares